Last reviewed · How we verify
Runzaozhiyang capsule agent simulation — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Runzaozhiyang capsule agent simulation (Runzaozhiyang capsule agent simulation) — Guizhou Tongjitang Pharmaceutical Co.,Ltd.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Runzaozhiyang capsule agent simulation TARGET | Runzaozhiyang capsule agent simulation | Guizhou Tongjitang Pharmaceutical Co.,Ltd | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Runzaozhiyang capsule agent simulation CI watch — RSS
- Runzaozhiyang capsule agent simulation CI watch — Atom
- Runzaozhiyang capsule agent simulation CI watch — JSON
- Runzaozhiyang capsule agent simulation alone — RSS
Cite this brief
Drug Landscape (2026). Runzaozhiyang capsule agent simulation — Competitive Intelligence Brief. https://druglandscape.com/ci/runzaozhiyang-capsule-agent-simulation. Accessed 2026-05-15.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab